Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
36.60B | 30.67B | 30.07B | 28.64B | 29.30B | Gross Profit |
8.55B | 7.17B | 7.40B | 6.69B | 6.77B | EBIT |
1.97B | 1.07B | 1.64B | 1.32B | 1.27B | EBITDA |
2.71B | 1.81B | 2.25B | 1.93B | 1.94B | Net Income Common Stockholders |
1.52B | 803.18M | 1.12B | 931.26M | 920.08M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
5.81B | 2.20B | 4.72B | 3.49B | 3.61B | Total Assets |
29.10B | 26.13B | 25.88B | 25.92B | 25.63B | Total Debt |
744.25M | 739.67M | 1.24B | 1.73B | 2.22B | Net Debt |
-5.07B | -1.46B | -3.49B | -1.77B | -1.38B | Total Liabilities |
9.99B | 8.51B | 8.93B | 9.54B | 10.12B | Stockholders Equity |
19.11B | 17.63B | 16.95B | 16.38B | 15.51B |
Cash Flow | Free Cash Flow | |||
3.96B | -1.56B | 1.94B | 631.65M | 1.58B | Operating Cash Flow |
4.33B | -1.44B | 2.41B | 1.04B | 2.18B | Investing Cash Flow |
-454.46M | -307.92M | -472.56M | -458.22M | -707.62M | Financing Cash Flow |
-266.50M | -780.77M | -710.32M | -698.41M | -708.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥15.64B | 7.35 | 4.12% | -0.51% | 6.17% | ||
76 Outperform | ¥15.37B | 8.48 | 2.71% | 9.10% | 18.98% | ||
76 Outperform | ¥160.02B | 14.76 | 2.33% | 3.68% | 18.75% | ||
75 Outperform | ¥24.64B | 14.01 | 5.39% | 1.57% | 20.22% | ||
62 Neutral | $6.80B | 11.04 | 2.79% | 4.42% | 2.67% | -25.07% | |
58 Neutral | ¥10.55B | 9.09 | 3.40% | -5.57% | -1.82% |